Status:
RECRUITING
Enhancing Renal Graft Function During Donor Anesthesia
Lead Sponsor:
Nazmy Edward Seif
Conditions:
Renal Failure Chronic
Transplant;Failure,Kidney
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Renal transplantation is now recognized as the treatment of choice for patients with end-stage renal disease. An optimum anesthetic regimen should enhance the function and perfusion of the transplante...
Eligibility Criteria
Inclusion
- end-stage renal disease, for living-donor kidney transplantation
Exclusion
- severe cardiac or hepatic dysfunction
- coagulopathy
Key Trial Info
Start Date :
December 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03778944
Start Date
December 20 2018
End Date
December 1 2025
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Al-Ainy Hospital, Cairo University
Cairo, Egypt